ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Modified NSAIDs Market Research Report 2026
Published Date: 2026-01-26
|
Report Code: QYRE-Auto-33O20052
Home | Market Reports
Global Modified NSAIDs Market Research Report 2026
BUY CHAPTERS

Global Modified NSAIDs Market Research Report 2026

Code: QYRE-Auto-33O20052
Report
2026-01-26
Pages:145
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Novartis
Bayer
AbbVie
Takeda
Sanofi
GSK
Johnson & Johnson
TEVA
Sun Pharma
Cipla Ltd
Dr. Reddy's
Aurobindo
Zydus Cadila
Torrent Pharma
Viatris
Apotex
Hikma
Jiangsu Hengrui Pharmaceuticals
SUZHOU HOMESUN PHARMACEUTICAL
CSPC Pharmaceutical
Zhejiang Sundoc Pharmaceutical

Modified NSAIDs Market Size

The global Modified NSAIDs market was valued at US$ 7328 million in 2025 and is anticipated to reach US$ 12209 million by 2032, at a CAGR of 8.0% from 2026 to 2032.

Modified NSAIDs Market

Modified NSAIDs Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Modified NSAIDs competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Modified nonsteroidal anti-inflammatory drugs (NSAIDs) are drugs developed from traditional NSAIDs (such as ibuprofen, indomethacin, and diclofenac) through molecular structure modification, improved formulation processes, or combination therapy strategies to reduce side effects and improve safety and efficacy. The main side effects of traditional NSAIDs are gastrointestinal damage, cardiovascular risk, and kidney impairment. Modified NSAIDs significantly reduce these risks and improve long-term safety through structural or formulation innovations. The product is priced at approximately $5,000 per kg, with global sales of approximately 1.46 million kg.
The upstream sector consists of active pharmaceutical ingredients (COX inhibitors, synthetic intermediates); the midstream sector comprises modified formulation companies (controlled-release tablets, transdermal patches, and combination formulations); and the downstream sector includes hospitals, pharmacies, and the OTC market. Future trends are safety-driven: selective COX-2 inhibitors and novel formulations will gradually replace traditional NSAIDs, especially in the elderly and patients with chronic diseases. Precision medicine and biologics will also become complementary treatment options.
The North American market for Modified NSAIDs is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Modified NSAIDs is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Modified NSAIDs include Pfizer, Novartis, Bayer, AbbVie, Takeda, Sanofi, GSK, Johnson & Johnson, Teva, Sun Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Modified NSAIDs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Modified NSAIDs. The Modified NSAIDs market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Modified NSAIDs market comprehensively. Regional market sizes by Type, by Application, by Application Scenarios, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Modified NSAIDs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Modified NSAIDs Market Report

Report Metric Details
Report Name Modified NSAIDs Market
Accounted market size in 2025 US$ 7328 million
Forecasted market size in 2032 US$ 12209 million
CAGR 8.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • COX-2 Selective Inhibitors
  • NO-NSAIDs (Nitric Oxide Releasers)
  • Others
Segment by Application Scenarios
  • Acute Pain Management
  • Chronic Inflammation (Rheumatoid Arthritis, Osteoarthritis)
  • Others
Segment by Manufacturing Process
  • Sustained-Release/Controlled-Release Tablets
  • Transdermal Patches, Gels
  • Microencapsulated Formulations
by Application
  • Hospital Clinical Department
  • Sports Medicine
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Novartis, Bayer, AbbVie, Takeda, Sanofi, GSK, Johnson & Johnson, Teva, Sun Pharma, Cipla, Dr. Reddy's, Aurobindo, Zydus Cadila, Torrent Pharma, Viatris, Apotex, Hikma, Jiangsu Hengrui Pharmaceuticals, Suzhou Homesun Pharmaceutical, CSPC Pharmaceutical, Zhejiang Sundoc Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Application Scenarios, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Modified NSAIDs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Modified NSAIDs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Modified NSAIDs Market growing?

Ans: The Modified NSAIDs Market witnessing a CAGR of 8.0% during the forecast period 2026-2032.

What is the Modified NSAIDs Market size in 2032?

Ans: The Modified NSAIDs Market size in 2032 will be US$ 12209 million.

Who are the main players in the Modified NSAIDs Market report?

Ans: The main players in the Modified NSAIDs Market are Pfizer, Novartis, Bayer, AbbVie, Takeda, Sanofi, GSK, Johnson & Johnson, Teva, Sun Pharma, Cipla, Dr. Reddy's, Aurobindo, Zydus Cadila, Torrent Pharma, Viatris, Apotex, Hikma, Jiangsu Hengrui Pharmaceuticals, Suzhou Homesun Pharmaceutical, CSPC Pharmaceutical, Zhejiang Sundoc Pharmaceutical

What are the Application segmentation covered in the Modified NSAIDs Market report?

Ans: The Applications covered in the Modified NSAIDs Market report are Hospital Clinical Department, Sports Medicine, Others

What are the Type segmentation covered in the Modified NSAIDs Market report?

Ans: The Types covered in the Modified NSAIDs Market report are COX-2 Selective Inhibitors, NO-NSAIDs (Nitric Oxide Releasers), Others

1 Modified NSAIDs Market Overview
1.1 Product Definition
1.2 Modified NSAIDs by Type
1.2.1 Global Modified NSAIDs Market Value by Type: 2025 vs 2032
1.2.2 COX-2 Selective Inhibitors
1.2.3 NO-NSAIDs (Nitric Oxide Releasers)
1.2.4 Others
1.3 Modified NSAIDs by Application Scenarios
1.3.1 Global Modified NSAIDs Market Value by Application Scenarios: 2025 vs 2032
1.3.2 Acute Pain Management
1.3.3 Chronic Inflammation (Rheumatoid Arthritis, Osteoarthritis)
1.3.4 Others
1.4 Modified NSAIDs by Manufacturing Process
1.4.1 Global Modified NSAIDs Market Value by Manufacturing Process: 2025 vs 2032
1.4.2 Sustained-Release/Controlled-Release Tablets
1.4.3 Transdermal Patches, Gels
1.4.4 Microencapsulated Formulations
1.5 Modified NSAIDs by Application
1.5.1 Global Modified NSAIDs Market Value by Application: 2025 vs 2032
1.5.2 Hospital Clinical Department
1.5.3 Sports Medicine
1.5.4 Others
1.6 Global Modified NSAIDs Market Size Estimates and Forecasts
1.6.1 Global Modified NSAIDs Revenue 2021–2032
1.6.2 Global Modified NSAIDs Sales 2021–2032
1.6.3 Global Modified NSAIDs Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Modified NSAIDs Market Competition by Manufacturers
2.1 Global Modified NSAIDs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Modified NSAIDs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Modified NSAIDs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Modified NSAIDs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Modified NSAIDs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Modified NSAIDs, Product Types and Applications
2.7 Global Key Manufacturers of Modified NSAIDs, Date of Entry into the Industry
2.8 Global Modified NSAIDs Market Competitive Situation and Trends
2.8.1 Global Modified NSAIDs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Modified NSAIDs Players Market Share by Revenue
2.8.3 Global Modified NSAIDs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Modified NSAIDs Market Scenario by Region
3.1 Global Modified NSAIDs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Modified NSAIDs Sales by Region: 2021–2032
3.2.1 Global Modified NSAIDs Sales by Region: 2021–2026
3.2.2 Global Modified NSAIDs Sales by Region: 2027–2032
3.3 Global Modified NSAIDs Revenue by Region: 2021–2032
3.3.1 Global Modified NSAIDs Revenue by Region: 2021–2026
3.3.2 Global Modified NSAIDs Revenue by Region: 2027–2032
3.4 North America Modified NSAIDs Market Facts & Figures by Country
3.4.1 North America Modified NSAIDs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Modified NSAIDs Sales by Country (2021–2032)
3.4.3 North America Modified NSAIDs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Modified NSAIDs Market Facts & Figures by Country
3.5.1 Europe Modified NSAIDs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Modified NSAIDs Sales by Country (2021–2032)
3.5.3 Europe Modified NSAIDs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Modified NSAIDs Market Facts & Figures by Region
3.6.1 Asia Pacific Modified NSAIDs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Modified NSAIDs Sales by Region (2021–2032)
3.6.3 Asia Pacific Modified NSAIDs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Modified NSAIDs Market Facts & Figures by Country
3.7.1 Latin America Modified NSAIDs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Modified NSAIDs Sales by Country (2021–2032)
3.7.3 Latin America Modified NSAIDs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Modified NSAIDs Market Facts & Figures by Country
3.8.1 Middle East and Africa Modified NSAIDs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Modified NSAIDs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Modified NSAIDs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Modified NSAIDs Sales by Type (2021–2032)
4.1.1 Global Modified NSAIDs Sales by Type (2021–2026)
4.1.2 Global Modified NSAIDs Sales by Type (2027–2032)
4.1.3 Global Modified NSAIDs Sales Market Share by Type (2021–2032)
4.2 Global Modified NSAIDs Revenue by Type (2021–2032)
4.2.1 Global Modified NSAIDs Revenue by Type (2021–2026)
4.2.2 Global Modified NSAIDs Revenue by Type (2027–2032)
4.2.3 Global Modified NSAIDs Revenue Market Share by Type (2021–2032)
4.3 Global Modified NSAIDs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Modified NSAIDs Sales by Application (2021–2032)
5.1.1 Global Modified NSAIDs Sales by Application (2021–2026)
5.1.2 Global Modified NSAIDs Sales by Application (2027–2032)
5.1.3 Global Modified NSAIDs Sales Market Share by Application (2021–2032)
5.2 Global Modified NSAIDs Revenue by Application (2021–2032)
5.2.1 Global Modified NSAIDs Revenue by Application (2021–2026)
5.2.2 Global Modified NSAIDs Revenue by Application (2027–2032)
5.2.3 Global Modified NSAIDs Revenue Market Share by Application (2021–2032)
5.3 Global Modified NSAIDs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Modified NSAIDs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Novartis Modified NSAIDs Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Bayer Modified NSAIDs Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 AbbVie
6.4.1 AbbVie Company Information
6.4.2 AbbVie Description and Business Overview
6.4.3 AbbVie Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 AbbVie Modified NSAIDs Product Portfolio
6.4.5 AbbVie Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Company Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Takeda Modified NSAIDs Product Portfolio
6.5.5 Takeda Recent Developments/Updates
6.6 Sanofi
6.6.1 Sanofi Company Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sanofi Modified NSAIDs Product Portfolio
6.6.5 Sanofi Recent Developments/Updates
6.7 GSK
6.7.1 GSK Company Information
6.7.2 GSK Description and Business Overview
6.7.3 GSK Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 GSK Modified NSAIDs Product Portfolio
6.7.5 GSK Recent Developments/Updates
6.8 Johnson & Johnson
6.8.1 Johnson & Johnson Company Information
6.8.2 Johnson & Johnson Description and Business Overview
6.8.3 Johnson & Johnson Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Johnson & Johnson Modified NSAIDs Product Portfolio
6.8.5 Johnson & Johnson Recent Developments/Updates
6.9 Teva
6.9.1 Teva Company Information
6.9.2 Teva Description and Business Overview
6.9.3 Teva Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Teva Modified NSAIDs Product Portfolio
6.9.5 Teva Recent Developments/Updates
6.10 Sun Pharma
6.10.1 Sun Pharma Company Information
6.10.2 Sun Pharma Description and Business Overview
6.10.3 Sun Pharma Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Sun Pharma Modified NSAIDs Product Portfolio
6.10.5 Sun Pharma Recent Developments/Updates
6.11 Cipla
6.11.1 Cipla Company Information
6.11.2 Cipla Description and Business Overview
6.11.3 Cipla Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Cipla Modified NSAIDs Product Portfolio
6.11.5 Cipla Recent Developments/Updates
6.12 Dr. Reddy's
6.12.1 Dr. Reddy's Company Information
6.12.2 Dr. Reddy's Description and Business Overview
6.12.3 Dr. Reddy's Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Dr. Reddy's Modified NSAIDs Product Portfolio
6.12.5 Dr. Reddy's Recent Developments/Updates
6.13 Aurobindo
6.13.1 Aurobindo Company Information
6.13.2 Aurobindo Description and Business Overview
6.13.3 Aurobindo Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Aurobindo Modified NSAIDs Product Portfolio
6.13.5 Aurobindo Recent Developments/Updates
6.14 Zydus Cadila
6.14.1 Zydus Cadila Company Information
6.14.2 Zydus Cadila Description and Business Overview
6.14.3 Zydus Cadila Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Zydus Cadila Modified NSAIDs Product Portfolio
6.14.5 Zydus Cadila Recent Developments/Updates
6.15 Torrent Pharma
6.15.1 Torrent Pharma Company Information
6.15.2 Torrent Pharma Description and Business Overview
6.15.3 Torrent Pharma Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Torrent Pharma Modified NSAIDs Product Portfolio
6.15.5 Torrent Pharma Recent Developments/Updates
6.16 Viatris
6.16.1 Viatris Company Information
6.16.2 Viatris Description and Business Overview
6.16.3 Viatris Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Viatris Modified NSAIDs Product Portfolio
6.16.5 Viatris Recent Developments/Updates
6.17 Apotex
6.17.1 Apotex Company Information
6.17.2 Apotex Description and Business Overview
6.17.3 Apotex Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Apotex Modified NSAIDs Product Portfolio
6.17.5 Apotex Recent Developments/Updates
6.18 Hikma
6.18.1 Hikma Company Information
6.18.2 Hikma Description and Business Overview
6.18.3 Hikma Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Hikma Modified NSAIDs Product Portfolio
6.18.5 Hikma Recent Developments/Updates
6.19 Jiangsu Hengrui Pharmaceuticals
6.19.1 Jiangsu Hengrui Pharmaceuticals Company Information
6.19.2 Jiangsu Hengrui Pharmaceuticals Description and Business Overview
6.19.3 Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Product Portfolio
6.19.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
6.20 Suzhou Homesun Pharmaceutical
6.20.1 Suzhou Homesun Pharmaceutical Company Information
6.20.2 Suzhou Homesun Pharmaceutical Description and Business Overview
6.20.3 Suzhou Homesun Pharmaceutical Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Suzhou Homesun Pharmaceutical Modified NSAIDs Product Portfolio
6.20.5 Suzhou Homesun Pharmaceutical Recent Developments/Updates
6.21 CSPC Pharmaceutical
6.21.1 CSPC Pharmaceutical Company Information
6.21.2 CSPC Pharmaceutical Description and Business Overview
6.21.3 CSPC Pharmaceutical Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 CSPC Pharmaceutical Modified NSAIDs Product Portfolio
6.21.5 CSPC Pharmaceutical Recent Developments/Updates
6.22 Zhejiang Sundoc Pharmaceutical
6.22.1 Zhejiang Sundoc Pharmaceutical Company Information
6.22.2 Zhejiang Sundoc Pharmaceutical Description and Business Overview
6.22.3 Zhejiang Sundoc Pharmaceutical Modified NSAIDs Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Zhejiang Sundoc Pharmaceutical Modified NSAIDs Product Portfolio
6.22.5 Zhejiang Sundoc Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Modified NSAIDs Industry Chain Analysis
7.2 Modified NSAIDs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Modified NSAIDs Production Mode & Process Analysis
7.4 Modified NSAIDs Sales and Marketing
7.4.1 Modified NSAIDs Sales Channels
7.4.2 Modified NSAIDs Distributors
7.5 Modified NSAIDs Customer Analysis
8 Modified NSAIDs Market Dynamics
8.1 Modified NSAIDs Industry Trends
8.2 Modified NSAIDs Market Drivers
8.3 Modified NSAIDs Market Challenges
8.4 Modified NSAIDs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Novartis
Bayer
AbbVie
Takeda
Sanofi
GSK
Johnson & Johnson
TEVA
Sun Pharma
Cipla Ltd
Dr. Reddy's
Aurobindo
Zydus Cadila
Torrent Pharma
Viatris
Apotex
Hikma
Jiangsu Hengrui Pharmaceuticals
SUZHOU HOMESUN PHARMACEUTICAL
CSPC Pharmaceutical
Zhejiang Sundoc Pharmaceutical
List of Tables
 Table 1. Global Modified NSAIDs Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Modified NSAIDs Market Value by Application Scenarios (US$ Million), 2025 vs 2032
 Table 3. Global Modified NSAIDs Market Value by Manufacturing Process (US$ Million), 2025 vs 2032
 Table 4. Global Modified NSAIDs Market Value by Application (US$ Million), 2025 vs 2032
 Table 5. Global Modified NSAIDs Market Competitive Situation by Manufacturers in 2025
 Table 6. Global Modified NSAIDs Sales (Tons) of Key Manufacturers (2021–2026)
 Table 7. Global Modified NSAIDs Sales Market Share by Manufacturers (2021–2026)
 Table 8. Global Modified NSAIDs Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 9. Global Modified NSAIDs Revenue Share by Manufacturers (2021–2026)
 Table 10. Global Market Modified NSAIDs Average Price (US$/kg) of Key Manufacturers (2021–2026)
 Table 11. Global Key Players of Modified NSAIDs, Industry Ranking, 2023 vs 2024 vs 2025
 Table 12. Global Key Manufacturers of Modified NSAIDs, Manufacturing Sites and Headquarters
 Table 13. Global Key Manufacturers of Modified NSAIDs, Product Types and Applications
 Table 14. Global Key Manufacturers of Modified NSAIDs, Date of Entry into the Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global Modified NSAIDs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Modified NSAIDs Revenue, 2025
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global Modified NSAIDs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 19. Global Modified NSAIDs Sales by Region (Tons), 2021–2026
 Table 20. Global Modified NSAIDs Sales Market Share by Region (2021–2026)
 Table 21. Global Modified NSAIDs Sales by Region (Tons), 2027–2032
 Table 22. Global Modified NSAIDs Sales Market Share by Region (2027–2032)
 Table 23. Global Modified NSAIDs Revenue by Region (US$ Million), 2021–2026
 Table 24. Global Modified NSAIDs Revenue Market Share by Region (2021–2026)
 Table 25. Global Modified NSAIDs Revenue by Region (US$ Million), 2027–2032
 Table 26. Global Modified NSAIDs Revenue Market Share by Region (2027–2032)
 Table 27. North America Modified NSAIDs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 28. North America Modified NSAIDs Sales by Country (Tons), 2021–2026
 Table 29. North America Modified NSAIDs Sales by Country (Tons), 2027–2032
 Table 30. North America Modified NSAIDs Revenue by Country (US$ Million), 2021–2026
 Table 31. North America Modified NSAIDs Revenue by Country (US$ Million), 2027–2032
 Table 32. Europe Modified NSAIDs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 33. Europe Modified NSAIDs Sales by Country (Tons), 2021–2026
 Table 34. Europe Modified NSAIDs Sales by Country (Tons), 2027–2032
 Table 35. Europe Modified NSAIDs Revenue by Country (US$ Million), 2021–2026
 Table 36. Europe Modified NSAIDs Revenue by Country (US$ Million), 2027–2032
 Table 37. Asia Pacific Modified NSAIDs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 38. Asia Pacific Modified NSAIDs Sales by Region (Tons), 2021–2026
 Table 39. Asia Pacific Modified NSAIDs Sales by Region (Tons), 2027–2032
 Table 40. Asia Pacific Modified NSAIDs Revenue by Region (US$ Million), 2021–2026
 Table 41. Asia Pacific Modified NSAIDs Revenue by Region (US$ Million), 2027–2032
 Table 42. Latin America Modified NSAIDs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 43. Latin America Modified NSAIDs Sales by Country (Tons), 2021–2026
 Table 44. Latin America Modified NSAIDs Sales by Country (Tons), 2027–2032
 Table 45. Latin America Modified NSAIDs Revenue by Country (US$ Million), 2021–2026
 Table 46. Latin America Modified NSAIDs Revenue by Country (US$ Million), 2027–2032
 Table 47. Middle East and Africa Modified NSAIDs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 48. Middle East and Africa Modified NSAIDs Sales by Country (Tons), 2021–2026
 Table 49. Middle East and Africa Modified NSAIDs Sales by Country (Tons), 2027–2032
 Table 50. Middle East and Africa Modified NSAIDs Revenue by Country (US$ Million), 2021–2026
 Table 51. Middle East and Africa Modified NSAIDs Revenue by Country (US$ Million), 2027–2032
 Table 52. Global Modified NSAIDs Sales (Tons) by Type (2021–2026)
 Table 53. Global Modified NSAIDs Sales (Tons) by Type (2027–2032)
 Table 54. Global Modified NSAIDs Sales Market Share by Type (2021–2026)
 Table 55. Global Modified NSAIDs Sales Market Share by Type (2027–2032)
 Table 56. Global Modified NSAIDs Revenue (US$ Million) by Type (2021–2026)
 Table 57. Global Modified NSAIDs Revenue (US$ Million) by Type (2027–2032)
 Table 58. Global Modified NSAIDs Revenue Market Share by Type (2021–2026)
 Table 59. Global Modified NSAIDs Revenue Market Share by Type (2027–2032)
 Table 60. Global Modified NSAIDs Price (US$/kg) by Type (2021–2026)
 Table 61. Global Modified NSAIDs Price (US$/kg) by Type (2027–2032)
 Table 62. Global Modified NSAIDs Sales (Tons) by Application (2021–2026)
 Table 63. Global Modified NSAIDs Sales (Tons) by Application (2027–2032)
 Table 64. Global Modified NSAIDs Sales Market Share by Application (2021–2026)
 Table 65. Global Modified NSAIDs Sales Market Share by Application (2027–2032)
 Table 66. Global Modified NSAIDs Revenue (US$ Million) by Application (2021–2026)
 Table 67. Global Modified NSAIDs Revenue (US$ Million) by Application (2027–2032)
 Table 68. Global Modified NSAIDs Revenue Market Share by Application (2021–2026)
 Table 69. Global Modified NSAIDs Revenue Market Share by Application (2027–2032)
 Table 70. Global Modified NSAIDs Price (US$/kg) by Application (2021–2026)
 Table 71. Global Modified NSAIDs Price (US$/kg) by Application (2027–2032)
 Table 72. Pfizer Company Information
 Table 73. Pfizer Description and Business Overview
 Table 74. Pfizer Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 75. Pfizer Modified NSAIDs Product
 Table 76. Pfizer Recent Developments/Updates
 Table 77. Novartis Company Information
 Table 78. Novartis Description and Business Overview
 Table 79. Novartis Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 80. Novartis Modified NSAIDs Product
 Table 81. Novartis Recent Developments/Updates
 Table 82. Bayer Company Information
 Table 83. Bayer Description and Business Overview
 Table 84. Bayer Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 85. Bayer Modified NSAIDs Product
 Table 86. Bayer Recent Developments/Updates
 Table 87. AbbVie Company Information
 Table 88. AbbVie Description and Business Overview
 Table 89. AbbVie Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 90. AbbVie Modified NSAIDs Product
 Table 91. AbbVie Recent Developments/Updates
 Table 92. Takeda Company Information
 Table 93. Takeda Description and Business Overview
 Table 94. Takeda Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 95. Takeda Modified NSAIDs Product
 Table 96. Takeda Recent Developments/Updates
 Table 97. Sanofi Company Information
 Table 98. Sanofi Description and Business Overview
 Table 99. Sanofi Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 100. Sanofi Modified NSAIDs Product
 Table 101. Sanofi Recent Developments/Updates
 Table 102. GSK Company Information
 Table 103. GSK Description and Business Overview
 Table 104. GSK Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 105. GSK Modified NSAIDs Product
 Table 106. GSK Recent Developments/Updates
 Table 107. Johnson & Johnson Company Information
 Table 108. Johnson & Johnson Description and Business Overview
 Table 109. Johnson & Johnson Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 110. Johnson & Johnson Modified NSAIDs Product
 Table 111. Johnson & Johnson Recent Developments/Updates
 Table 112. Teva Company Information
 Table 113. Teva Description and Business Overview
 Table 114. Teva Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 115. Teva Modified NSAIDs Product
 Table 116. Teva Recent Developments/Updates
 Table 117. Sun Pharma Company Information
 Table 118. Sun Pharma Description and Business Overview
 Table 119. Sun Pharma Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 120. Sun Pharma Modified NSAIDs Product
 Table 121. Sun Pharma Recent Developments/Updates
 Table 122. Cipla Company Information
 Table 123. Cipla Description and Business Overview
 Table 124. Cipla Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 125. Cipla Modified NSAIDs Product
 Table 126. Cipla Recent Developments/Updates
 Table 127. Dr. Reddy's Company Information
 Table 128. Dr. Reddy's Description and Business Overview
 Table 129. Dr. Reddy's Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 130. Dr. Reddy's Modified NSAIDs Product
 Table 131. Dr. Reddy's Recent Developments/Updates
 Table 132. Aurobindo Company Information
 Table 133. Aurobindo Description and Business Overview
 Table 134. Aurobindo Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 135. Aurobindo Modified NSAIDs Product
 Table 136. Aurobindo Recent Developments/Updates
 Table 137. Zydus Cadila Company Information
 Table 138. Zydus Cadila Description and Business Overview
 Table 139. Zydus Cadila Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 140. Zydus Cadila Modified NSAIDs Product
 Table 141. Zydus Cadila Recent Developments/Updates
 Table 142. Torrent Pharma Company Information
 Table 143. Torrent Pharma Description and Business Overview
 Table 144. Torrent Pharma Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 145. Torrent Pharma Modified NSAIDs Product
 Table 146. Torrent Pharma Recent Developments/Updates
 Table 147. Viatris Company Information
 Table 148. Viatris Description and Business Overview
 Table 149. Viatris Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 150. Viatris Modified NSAIDs Product
 Table 151. Viatris Recent Developments/Updates
 Table 152. Apotex Company Information
 Table 153. Apotex Description and Business Overview
 Table 154. Apotex Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 155. Apotex Modified NSAIDs Product
 Table 156. Apotex Recent Developments/Updates
 Table 157. Hikma Company Information
 Table 158. Hikma Description and Business Overview
 Table 159. Hikma Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 160. Hikma Modified NSAIDs Product
 Table 161. Hikma Recent Developments/Updates
 Table 162. Jiangsu Hengrui Pharmaceuticals Company Information
 Table 163. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
 Table 164. Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 165. Jiangsu Hengrui Pharmaceuticals Modified NSAIDs Product
 Table 166. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
 Table 167. Suzhou Homesun Pharmaceutical Company Information
 Table 168. Suzhou Homesun Pharmaceutical Description and Business Overview
 Table 169. Suzhou Homesun Pharmaceutical Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 170. Suzhou Homesun Pharmaceutical Modified NSAIDs Product
 Table 171. Suzhou Homesun Pharmaceutical Recent Developments/Updates
 Table 172. CSPC Pharmaceutical Company Information
 Table 173. CSPC Pharmaceutical Description and Business Overview
 Table 174. CSPC Pharmaceutical Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 175. CSPC Pharmaceutical Modified NSAIDs Product
 Table 176. CSPC Pharmaceutical Recent Developments/Updates
 Table 177. Zhejiang Sundoc Pharmaceutical Company Information
 Table 178. Zhejiang Sundoc Pharmaceutical Description and Business Overview
 Table 179. Zhejiang Sundoc Pharmaceutical Modified NSAIDs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 180. Zhejiang Sundoc Pharmaceutical Modified NSAIDs Product
 Table 181. Zhejiang Sundoc Pharmaceutical Recent Developments/Updates
 Table 182. Key Raw Materials Lists
 Table 183. Raw Materials Key Suppliers Lists
 Table 184. Modified NSAIDs Distributors List
 Table 185. Modified NSAIDs Customers List
 Table 186. Modified NSAIDs Market Trends
 Table 187. Modified NSAIDs Market Drivers
 Table 188. Modified NSAIDs Market Challenges
 Table 189. Modified NSAIDs Market Restraints
 Table 190. Research Programs/Design for This Report
 Table 191. Key Data Information from Secondary Sources
 Table 192. Key Data Information from Primary Sources
 Table 193. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Modified NSAIDs
 Figure 2. Global Modified NSAIDs Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Modified NSAIDs Market Share by Type: 2025 & 2032
 Figure 4. COX-2 Selective Inhibitors Product Picture
 Figure 5. NO-NSAIDs (Nitric Oxide Releasers) Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Modified NSAIDs Market Value by Application Scenarios (US$ Million), 2021–2032
 Figure 8. Global Modified NSAIDs Market Share by Application Scenarios: 2025 vs 2032
 Figure 9. Acute Pain Management Product Picture
 Figure 10. Chronic Inflammation (Rheumatoid Arthritis, Osteoarthritis) Product Picture
 Figure 11. Others Product Picture
 Figure 12. Global Modified NSAIDs Market Value by Manufacturing Process (US$ Million), 2021–2032
 Figure 13. Global Modified NSAIDs Market Share by Manufacturing Process: 2025 vs 2032
 Figure 14. Sustained-Release/Controlled-Release Tablets Product Picture
 Figure 15. Transdermal Patches, Gels Product Picture
 Figure 16. Microencapsulated Formulations Product Picture
 Figure 17. Global Modified NSAIDs Market Value by Application (US$ Million), 2021–2032
 Figure 18. Global Modified NSAIDs Market Share by Application: 2025 & 2032
 Figure 19. Hospital Clinical Department
 Figure 20. Sports Medicine
 Figure 21. Others
 Figure 22. Global Modified NSAIDs Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 23. Global Modified NSAIDs Market Size (US$ Million), 2021–2032
 Figure 24. Global Modified NSAIDs Sales (Tons), 2021–2032
 Figure 25. Global Modified NSAIDs Average Price (US$/kg), 2021–2032
 Figure 26. Modified NSAIDs Report Years Considered
 Figure 27. Modified NSAIDs Sales Share by Manufacturers in 2025
 Figure 28. Global Modified NSAIDs Revenue Share by Manufacturers in 2025
 Figure 29. Top 5 and Top 10 Global Modified NSAIDs Players: Market Share by Revenue in Modified NSAIDs in 2025
 Figure 30. Modified NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 31. Global Modified NSAIDs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 32. North America Modified NSAIDs Sales Market Share by Country (2021–2032)
 Figure 33. North America Modified NSAIDs Revenue Market Share by Country (2021–2032)
 Figure 34. United States Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Canada Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Europe Modified NSAIDs Sales Market Share by Country (2021–2032)
 Figure 37. Europe Modified NSAIDs Revenue Market Share by Country (2021–2032)
 Figure 38. Germany Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. France Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. U.K. Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Italy Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Russia Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Asia Pacific Modified NSAIDs Sales Market Share by Region (2021–2032)
 Figure 44. Asia Pacific Modified NSAIDs Revenue Market Share by Region (2021–2032)
 Figure 45. China Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Japan Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. South Korea Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. India Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Australia Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. China Taiwan Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Southeast Asia Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Latin America Modified NSAIDs Sales Market Share by Country (2021–2032)
 Figure 53. Latin America Modified NSAIDs Revenue Market Share by Country (2021–2032)
 Figure 54. Mexico Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Brazil Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Argentina Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Colombia Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. Middle East and Africa Modified NSAIDs Sales Market Share by Country (2021–2032)
 Figure 59. Middle East and Africa Modified NSAIDs Revenue Market Share by Country (2021–2032)
 Figure 60. Turkey Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 61. Saudi Arabia Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 62. UAE Modified NSAIDs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 63. Global Sales Market Share of Modified NSAIDs by Type (2021–2032)
 Figure 64. Global Revenue Market Share of Modified NSAIDs by Type (2021–2032)
 Figure 65. Global Modified NSAIDs Price (US$/kg) by Type (2021–2032)
 Figure 66. Global Sales Market Share of Modified NSAIDs by Application (2021–2032)
 Figure 67. Global Revenue Market Share of Modified NSAIDs by Application (2021–2032)
 Figure 68. Global Modified NSAIDs Price (US$/kg) by Application (2021–2032)
 Figure 69. Modified NSAIDs Value Chain
 Figure 70. Channels of Distribution (Direct Vs Distribution)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions